Christopher Kurz1, Florian Kamp2, Yang-Kyun Park3, Christoph Zöllner4, Simon Rit5, David Hansen6, Mark Podesta7, Gregory C Sharp3, Minglun Li2, Michael Reiner2, Jan Hofmaier2, Sebastian Neppl2, Christian Thieke2, Reinoud Nijhuis2, Ute Ganswindt2, Claus Belka2, Brian A Winey3, Katia Parodi4, Guillaume Landry4. 1. Department of Radiation Oncology, LMU Munich, Munich 81377, Germany and Department of Medical Physics, Ludwig-Maximilians-Universität München, Garching bei München 85748, Germany. 2. Department of Radiation Oncology, LMU Munich, Munich 81377, Germany. 3. Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114. 4. Department of Medical Physics, Ludwig-Maximilians-Universität München, Garching bei München 85748, Germany. 5. Université de Lyon, CREATIS, CNRS UMR5220m Inserm U1044, INSA-Lyon, Université Lyon 1, Lyon F69373, France. 6. Department of Oncology, Aarhus University Hospital, Aarhus 8000, Denmark. 7. Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht 6229 ET, The Netherlands.
Abstract
PURPOSE: This work aims at investigating intensity corrected cone-beam x-ray computed tomography (CBCT) images for accurate dose calculation in adaptive intensity modulated proton therapy (IMPT) for prostate and head and neck (H&N) cancer. A deformable image registration (DIR)-based method and a scatter correction approach using the image data obtained from DIR as prior are characterized and compared on the basis of the same clinical patient cohort for the first time. METHODS: Planning CT (pCT) and daily CBCT data (reconstructed images and measured projections) of four H&N and four prostate cancer patients have been considered in this study. A previously validated Morphons algorithm was used for DIR of the planning CT to the current CBCT image, yielding a so-called virtual CT (vCT). For the first time, this approach was translated from H&N to prostate cancer cases in the scope of proton therapy. The warped pCT images were also used as prior for scatter correction of the CBCT projections for both tumor sites. Single field uniform dose and IMPT (only for H&N cases) treatment plans have been generated with a research version of a commercial planning system. Dose calculations on vCT and scatter corrected CBCT (CBCTcor) were compared by means of the proton range and a gamma-index analysis. For the H&N cases, an additional diagnostic replanning CT (rpCT) acquired within three days of the CBCT served as additional reference. For the prostate patients, a comprehensive contour comparison of CBCT and vCT, using a trained physician's delineation, was performed. RESULTS: A high agreement of vCT and CBCTcor was found in terms of the proton range and gamma-index analysis. For all patients and indications between 95% and 100% of the proton dose profiles in beam's eye view showed a range agreement of better than 3 mm. The pass rate in a (2%,2 mm) gamma-comparison was between 96% and 100%. For H&N patients, an equivalent agreement of vCT and CBCTcor to the reference rpCT was observed. However, for the prostate cases, an insufficient accuracy of the vCT contours retrieved from DIR was found, while the CBCTcor contours showed very high agreement to the contours delineated on the raw CBCT. CONCLUSIONS: For H&N patients, no considerable differences of vCT and CBCTcor were found. For prostate cases, despite the high dosimetric agreement, the DIR yields incorrect contours, probably due to the more pronounced anatomical changes in the abdomen and the reduced soft-tissue contrast in the CBCT. Using the vCT as prior, these inaccuracies can be overcome and images suitable for accurate delineation and dose calculation in CBCT-based adaptive IMPT can be retrieved from scatter correction of the CBCT projections.
PURPOSE: This work aims at investigating intensity corrected cone-beam x-ray computed tomography (CBCT) images for accurate dose calculation in adaptive intensity modulated proton therapy (IMPT) for prostate and head and neck (H&N) cancer. A deformable image registration (DIR)-based method and a scatter correction approach using the image data obtained from DIR as prior are characterized and compared on the basis of the same clinical patient cohort for the first time. METHODS: Planning CT (pCT) and daily CBCT data (reconstructed images and measured projections) of four H&N and four prostate cancerpatients have been considered in this study. A previously validated Morphons algorithm was used for DIR of the planning CT to the current CBCT image, yielding a so-called virtual CT (vCT). For the first time, this approach was translated from H&N to prostate cancer cases in the scope of proton therapy. The warped pCT images were also used as prior for scatter correction of the CBCT projections for both tumor sites. Single field uniform dose and IMPT (only for H&N cases) treatment plans have been generated with a research version of a commercial planning system. Dose calculations on vCT and scatter corrected CBCT (CBCTcor) were compared by means of the proton range and a gamma-index analysis. For the H&N cases, an additional diagnostic replanning CT (rpCT) acquired within three days of the CBCT served as additional reference. For the prostate patients, a comprehensive contour comparison of CBCT and vCT, using a trained physician's delineation, was performed. RESULTS: A high agreement of vCT and CBCTcor was found in terms of the proton range and gamma-index analysis. For all patients and indications between 95% and 100% of the proton dose profiles in beam's eye view showed a range agreement of better than 3 mm. The pass rate in a (2%,2 mm) gamma-comparison was between 96% and 100%. For H&N patients, an equivalent agreement of vCT and CBCTcor to the reference rpCT was observed. However, for the prostate cases, an insufficient accuracy of the vCT contours retrieved from DIR was found, while the CBCTcor contours showed very high agreement to the contours delineated on the raw CBCT. CONCLUSIONS: For H&N patients, no considerable differences of vCT and CBCTcor were found. For prostate cases, despite the high dosimetric agreement, the DIR yields incorrect contours, probably due to the more pronounced anatomical changes in the abdomen and the reduced soft-tissue contrast in the CBCT. Using the vCT as prior, these inaccuracies can be overcome and images suitable for accurate delineation and dose calculation in CBCT-based adaptive IMPT can be retrieved from scatter correction of the CBCT projections.
Authors: Bo Yang; Yankui Chang; Yongguang Liang; Zhiqun Wang; Xi Pei; Xie George Xu; Jie Qiu Journal: Front Oncol Date: 2022-05-30 Impact factor: 5.738
Authors: Mislav Bobić; Arthur Lalonde; Gregory C Sharp; Clemens Grassberger; Joost M Verburg; Brian A Winey; Antony J Lomax; Harald Paganetti Journal: Phys Med Biol Date: 2021-02-25 Impact factor: 3.609
Authors: Alexander Stanforth; Liyong Lin; Jonathan J Beitler; James R Janopaul-Naylor; Chih-Wei Chang; Robert H Press; Sagar A Patel; Jennifer Zhao; Bree Eaton; Eduard E Schreibmann; James Jung; Duncan Bohannon; Tian Liu; Xiaofeng Yang; Mark W McDonald; Jun Zhou Journal: J Appl Clin Med Phys Date: 2022-02-07 Impact factor: 2.243
Authors: Olga M Dona Lemus; Yi-Fang Wang; Fiona Li; Sachin Jambawalikar; David P Horowitz; Yuanguang Xu; Cheng-Shie Wuu Journal: J Appl Clin Med Phys Date: 2022-03-25 Impact factor: 2.243